Peer-influenced content. Sources you trust. No registration required. This is HCN.
JAMA Network
The Lumipulse G β-Amyloid Ratio (1-42/1-40) test could potentially eliminate the need for positron emission tomography (PET) scans to assess amyloid plaques in patients’ brains, Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, said in a statement.
Neurology July 5th 2022
Pediatric Blood & Cancer
This Children’s Oncology Group report recommends new guidance on administering radiotherapy among children with cancer. Questions are answered around imaging protocols, dose reduction, setup correction, and adaptive therapy.
Hematology October 29th 2021